Prospera Financial Services Inc
Position in SLS — SELLAS Life Sciences Group, Inc.
CIK 1541625
Dallas, TX
Position in SLS
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$267,436
New position
Shares Held
18,119
first reported quarter
Ownership
0.010%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#8
of 19 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Prospera Financial Services Inc holds $8,455,010 across 19 Biotechnology names. SLS ranks #8 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,113 | $2,564,620 | |
| 2 | PBYI |
Puma Biotechnology, Inc.
|
158,762 | $1,287,559 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,571 | $1,277,092 | |
| 4 | TGTX |
Tg Therapeutics, Inc.
|
12,625 | $693,617 | |
| 5 | VKTX |
Viking Therapeutics, Inc.
|
9,781 | $381,556 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
4,194 | $332,542 | |
| 7 | SRPT |
Sarepta Therapeutics, Inc.
|
17,042 | $306,244 | |
| 8 | SLS |
SELLAS Life Sciences Group, Inc.
This page
|
18,119 | $267,436 |
All Filings in SLS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $267,436 | 18,119 | Shares | Sole | 2026-07-15 | |
| No filing history on record for this holder in this stock. | ||||||